Thrombus straddling a patent foramen ovale in a patient with pulmonary embolism related to essential thrombocythemia Jiang-Shan TanXin-Xin YanLu Hua Images in Hematology 02 January 2021 Pages: 159 - 160
Cytokeratin expression in therapy-related leukemia Hiromi KinoshitaDaisuke OkamuraYasuhiro Ebihara Images in Hematology 01 January 2021 Pages: 161 - 162
Characterization of hereditary red blood cell membranopathies using combined targeted next-generation sequencing and osmotic gradient ektacytometry Joan-Lluis Vives-CorronsElena KrishnevskayaAgueda Ancochea Original Article 19 October 2020 Pages: 163 - 174
The impact of autoimmune cytopenias on the clinical course and survival of Hodgkin lymphoma László Imre PinczésRoxána SzabóÁrpád Illés Original Article 15 October 2020 Pages: 175 - 182
Intensity of immune/clotting assays relate to multiple antiphospholipid antibody positivity in thrombotic primary antiphospholipid syndrome Paul R. J. AmesMira MerashliAntonio Ciampa Original Article 08 October 2020 Pages: 183 - 189
Direct oral anticoagulants in patients with severe inherited thrombophilia: a single-center cohort study Joanna ZukElzbieta Papuga-SzelaAnetta Undas Original Article 11 October 2020 Pages: 190 - 198
Platelet indices as a predictive marker in neonatal sepsis and respiratory distress in preterm prelabor rupture of membranes Sanjay MishraShyampyari JaiswarNeetu Mishra Original Article 27 October 2020 Pages: 199 - 206
Clinical and prognostic significance of t(4;14) translocation in multiple myeloma in the era of novel agents Shuku SatoWataru KamataYotaro Tamai Original Article 19 September 2020 Pages: 207 - 213
Chronic myeloid leukemia in solid organ transplant patients: a case series Irina AmitaiAdi Shacham AbulafiaJeffrey H. Lipton Original Article 06 October 2020 Pages: 214 - 218
Once-weekly vs. twice-weekly carfilzomib dosing in a subgroup of Japanese relapsed and refractory multiple myeloma patients from a randomized phase 3 trial (A.R.R.O.W.) and comparison with ENDEAVOR Naoki TakezakoHirohiko ShibayamaShinsuke Iida Original Article 10 October 2020 Pages: 219 - 230
Transcriptional heterogeneity of clonal plasma cells and immune evasion in immunoglobulin light chain amyloidosis Yujia WangLushuang XuJin Lu Original Article 10 October 2020 Pages: 231 - 242
Inhibition of CDK4/6 and autophagy synergistically induces apoptosis in t(8;21) acute myeloid leukemia cells Kana NakataniHidemasa MatsuoSouichi Adachi Original Article 17 October 2020 Pages: 243 - 253
Salt-inducible kinase inhibition sensitizes human acute myeloid leukemia cells to all-trans retinoic acid-induced differentiation Xue-Wen ZhangXing ShenYu-Wen Cong Original Article 19 October 2020 Pages: 254 - 262
Clinical features of 47 secondary hemophagocytic lymphohistiocytosis patients complicated with capillary leak syndrome Changfeng ManMengmeng WangHongxia Qiu Original Article 09 October 2020 Pages: 263 - 270
Medical database analysis of japanese multiple myeloma patients with planned stem cell transplantation (MEDALIST) – a focus on healthcare resource utilization and cost Shinsuke IidaTadao IshidaTakanori Teshima Original Article 15 October 2020 Pages: 271 - 278
The clonal evolution during long-term clinical course of multiple myeloma Yuko MishimaYuji MishimaYasuhito Terui Case Report 30 August 2020 Pages: 279 - 284
Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion Shuki OyaSatoshi MorishigeKoji Nagafuji Case Report 19 September 2020 Pages: 285 - 289
Donor-derived myelodysplastic syndrome after allogeneic stem cell transplantation in a family with germline GATA2 mutation Naoki SakataMunehiro OkanoKeisuke Sugimoto Case Report 31 August 2020 Pages: 290 - 296
Ruxolitinib for hematopoietic cell transplantation-associated hemophagocytic lymphohistiocytosis Rintaro OnoMiho AshiaraiDaisuke Hasegawa Case Report 26 September 2020 Pages: 297 - 301
Bone marrow transplantation from a human leukocyte antigen-mismatched unrelated donor in a case with C1q deficiency associated with refractory systemic lupus erythematosus Risa MatsumuraShinji MochizukiMasao Kobayashi Case Report 30 September 2020 Pages: 302 - 307
Correction to: FLEND (nelarabine, fludarabine, and etoposide) for relapsed T-cell acute lymphoblastic leukemia in children: a report from Japan Children’s Cancer Group Tadashi KumamotoHiroaki GotoHidemi Toyoda Correction 23 January 2021 Pages: 308 - 309